Based on the aforementioned results, we speculated that HOXA11-AS may play an important role in NSCLC development and progression by regulating the expression of various pathways and genes, especially DOCK8 and TGF-beta pathway. This evidence concerns the gene HOXA11 and non-small cell lung carcinoma.